Lincoln Pharmaceuticals consolidated net profit declines 12.40% in the March 2022 quarter

Sales rise 28.91% to Rs 102.59 crore

Net profit of Lincoln Pharmaceuticals declined 12.40% to Rs 11.02 crore in the quarter ended March 2022 as against Rs 12.58 crore during the previous quarter ended March 2021. Sales rose 28.91% to Rs 102.59 crore in the quarter ended March 2022 as against Rs 79.58 crore during the previous quarter ended March 2021.

For the full year,net profit rose 11.42% to Rs 69.36 crore in the year ended March 2022 as against Rs 62.25 crore during the previous year ended March 2021. Sales rose 11.30% to Rs 472.12 crore in the year ended March 2022 as against Rs 424.19 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales102.5979.58 29 472.12424.19 11 OPM %17.0119.16 -20.2220.55 - PBDT18.7717.20 9 104.0391.28 14 PBT16.7715.31 10 95.9483.72 15 NP11.0212.58 -12 69.3662.25 11

Powered by Capital Market - Live News